X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4231) 4231
ionomycin - pharmacology (3634) 3634
animals (2700) 2700
humans (1918) 1918
calcium - metabolism (1518) 1518
tetradecanoylphorbol acetate - pharmacology (1367) 1367
cells, cultured (989) 989
rats (958) 958
mice (929) 929
ionomycin (927) 927
ionophores - pharmacology (863) 863
biochemistry & molecular biology (831) 831
male (740) 740
cell biology (634) 634
female (628) 628
calcium (613) 613
immunology (607) 607
kinetics (602) 602
cell line (594) 594
activation (528) 528
in vitro techniques (466) 466
ethers - pharmacology (465) 465
signal transduction (415) 415
abridged index medicus (394) 394
phosphorylation (390) 390
physiology (385) 385
calcium - physiology (384) 384
calcium - pharmacology (381) 381
time factors (353) 353
enzyme inhibitors - pharmacology (345) 345
expression (344) 344
protein kinase c - metabolism (343) 343
lymphocyte activation - drug effects (341) 341
dose-response relationship, drug (329) 329
cells (325) 325
calcimycin - pharmacology (307) 307
egtazic acid - pharmacology (305) 305
tumor cells, cultured (288) 288
t-lymphocytes - drug effects (281) 281
t-lymphocytes - immunology (281) 281
lymphocyte activation (268) 268
cytosol - metabolism (260) 260
neurosciences (251) 251
apoptosis (241) 241
t-lymphocytes - metabolism (241) 241
flow cytometry (236) 236
molecular sequence data (224) 224
adult (220) 220
lymphocytes (218) 218
signal transduction - drug effects (216) 216
transfection (203) 203
thapsigargin - pharmacology (202) 202
mice, inbred c57bl (201) 201
enzyme activation (197) 197
pharmacology & pharmacy (195) 195
cattle (192) 192
rats, sprague-dawley (190) 190
proteins (183) 183
colforsin - pharmacology (182) 182
protein-kinase-c (182) 182
biophysics (178) 178
receptor (176) 176
fura-2 (173) 173
membrane potentials - drug effects (173) 173
rna, messenger - metabolism (170) 170
fluorescent dyes (169) 169
research (169) 169
cell membrane - metabolism (166) 166
thapsigargin (164) 164
adenosine triphosphate - pharmacology (163) 163
inhibition (160) 160
base sequence (156) 156
endocrinology & metabolism (150) 150
egtazic acid - analogs & derivatives (148) 148
interleukin-2 - biosynthesis (148) 148
gene expression (147) 147
secretion (147) 147
enzyme activation - drug effects (145) 145
mice, inbred balb c (145) 145
protein kinase c - antagonists & inhibitors (145) 145
cyclic amp - metabolism (144) 144
multidisciplinary sciences (144) 144
hydrogen-ion concentration (143) 143
physiological aspects (143) 143
rna, messenger - genetics (143) 143
gene expression regulation - drug effects (142) 142
intracellular calcium (142) 142
analysis (139) 139
t cells (139) 139
cell division - drug effects (134) 134
rats, wistar (134) 134
apoptosis - drug effects (132) 132
calcium channel blockers - pharmacology (132) 132
carbachol - pharmacology (131) 131
jurkat cells (131) 131
chelating agents - pharmacology (127) 127
patch-clamp techniques (127) 127
release (126) 126
gene-expression (125) 125
in-vitro (124) 124
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 2014, Volume 20, Issue 4, pp. 425 - 429
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 08/2012, Volume 32, Issue 33, pp. 11356 - 11364
Journal Article
Journal Article
NATURE NEUROSCIENCE, ISSN 1097-6256, 09/2005, Volume 8, Issue 9, pp. 1160 - 1168
Exocytosis proceeds by either full fusion or 'kiss-and-run' between vesicle and plasma membrane. Switching between these two modes permits the cell to regulate... 
TRANSMITTER RELEASE | VESICLE FUSION | PROTEIN-KINASE-C | PRESYNAPTIC INHIBITION | EXOCYTOSIS | NEUROTRANSMITTER RELEASE | RECEPTOR | BETA-GAMMA-SUBUNITS | NEUROSCIENCES | FUSION PORE KINETICS | SECRETORY GRANULES | GTP-Binding Protein beta Subunits - pharmacology | Receptors, G-Protein-Coupled - metabolism | Recombinant Fusion Proteins - pharmacology | Calcium - metabolism | Analgesics, Opioid - pharmacology | Membrane Potentials - radiation effects | Patch-Clamp Techniques - methods | Somatostatin - pharmacology | Dynamins - pharmacology | Adenosine Triphosphate - pharmacology | Neural Inhibition - physiology | Drug Interactions | Protein Kinase C - metabolism | Potassium Chloride - pharmacology | Action Potentials - radiation effects | GTP-Binding Protein beta Subunits - metabolism | Chromaffin Cells - drug effects | Electric Stimulation - methods | Action Potentials - drug effects | Ionophores - pharmacology | Pertussis Toxin - pharmacology | Membrane Potentials - drug effects | Protein Kinases - pharmacology | GTP-Binding Protein gamma Subunits - metabolism | Enkephalin, Ala-MePhe-Gly- - pharmacology | Cells, Cultured | Enzyme Inhibitors - pharmacology | Rats | Thionucleotides - pharmacology | Enzyme Activation - drug effects | Adenosine Triphosphate - analogs & derivatives | Adrenal Medulla - cytology | Action Potentials - physiology | Chromaffin Cells - metabolism | Animals | Ionomycin - pharmacology | Muscarine - pharmacology | Electrochemistry - methods | Dose-Response Relationship, Radiation | Enzyme Activation - physiology | Neural Inhibition - drug effects | Chromaffin cells | Physiological aspects | Cell receptors | Research | G proteins | Protein kinases | Index Medicus
Journal Article
FASEB Journal, ISSN 0892-6638, 03/2006, Volume 20, Issue 3, pp. 466 - 475
Hypoxia-inducible factors (HIFs) are ubiquitous transcription factors that mediate adaptation to hypoxia by inducing specific sets of target genes. It is well... 
Oxygen-sensitive cells | Protein kinase C | Carotid body | Protein translation | PC12 cells | MAMMALIAN TARGET | protein translation | INDUCIBLE FACTOR-1-ALPHA | oxygen-sensitive cells | BIOCHEMISTRY & MOLECULAR BIOLOGY | carotid body | KIDNEY HEK293 CELLS | CELL BIOLOGY | HEK-293 CELLS | MESSENGER-RNA | TYROSINE-HYDROXYLASE GENE | BIOLOGY | TUMOR-SUPPRESSOR PROTEIN | CHANNEL ACTIVITY | protein kinase C | Cell Hypoxia - physiology | Protein Biosynthesis | Nitriles - pharmacology | Protein Kinase C-alpha - metabolism | Humans | RNA, Messenger - metabolism | Kidney | Cell Line - drug effects | Isoquinolines - pharmacology | Basic Helix-Loop-Helix Transcription Factors - biosynthesis | Indoles - pharmacology | Flavonoids - pharmacology | Hypoxia-Inducible Factor 1, alpha Subunit - biosynthesis | Protein Synthesis Inhibitors - pharmacology | Calcium Signaling | Cell Line - metabolism | Protein Kinase C-alpha - antagonists & inhibitors | Butadienes - pharmacology | Aryl Hydrocarbon Receptor Nuclear Translocator - analysis | Basic Helix-Loop-Helix Transcription Factors - genetics | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | RNA, Small Interfering - pharmacology | Rats | Sulfonamides - pharmacology | Sirolimus - pharmacology | Cycloheximide - pharmacology | PC12 Cells - drug effects | Animals | PC12 Cells - metabolism | Protein Kinases - physiology | Ionomycin - pharmacology | Polyribosomes - metabolism | RNA Caps - physiology | TOR Serine-Threonine Kinases | Carbazoles - pharmacology | Benzylamines - pharmacology | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, pp. e0139212 - e0139212
Background Increased endocannabinoid tonus by dual-action fatty acid amide hydrolase (FAAH) and substrate selective cyclooxygenase (COX-2) inhibitors is a... 
IBUPROFEN | ENZYME | COX-2 | OXYGENATION | ENDOCANNABINOIDS | MULTIDISCIPLINARY SCIENCES | ANANDAMIDE | INDOMETHACIN | FLURBIPROFEN | LINEAR-MODELS | ANTIINFLAMMATORY DRUGS | Endocannabinoids - metabolism | Stereoisomerism | Humans | Brain - enzymology | Male | Arachidonic Acids - metabolism | Isoenzymes - metabolism | Benzamides - pharmacology | Carbamates - pharmacology | Amides - pharmacology | Amidohydrolases - metabolism | Amidohydrolases - antagonists & inhibitors | Polyunsaturated Alkamides - metabolism | Cyclooxygenase Inhibitors - pharmacology | Hydrolysis | Animals | Arachidonic Acid - pharmacology | Cyclooxygenase 2 - metabolism | Lipid Metabolism - drug effects | Lipopolysaccharides - pharmacology | Amides - chemistry | Ionomycin - pharmacology | RAW 264.7 Cells | Mice | Cyclooxygenase 1 - metabolism | Flurbiprofen - pharmacology | Interferon-gamma - pharmacology | Prostaglandins - metabolism | Brain | COX-2 inhibitors | Neurosciences | Lipids | Enantiomers | Arachidonic acid | Macrophages | Prostaglandin endoperoxide synthase | Pain | 2-Arachidonylglycerol | Rodents | Inhibition | Nonsteroidal anti-inflammatory drugs | Flurbiprofen | Functional foods & nutraceuticals | Fatty-acid amide hydrolase | Enzymes | Hydrolase | Substrate inhibition | Pharmacology | Prostaglandin D2 | Fatty acids | Substrates | Anandamide | Environmental science | Inhibitors | Cyclooxygenase-1 | Interferon | Cyclooxygenase-2 | Oxygenation | Pharmaceuticals | Index Medicus | Basic Medicine | Farmakologi och toxikologi | Medical and Health Sciences | Pharmacology and Toxicology | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 11/2012, Volume 303, Issue 9, pp. C991 - C999
Journal Article
Blood, ISSN 0006-4971, 01/2007, Volume 109, Issue 1, pp. 228 - 234
The molecular mechanisms by which mesenchymal stem cells (MSCs) suppress T-cell proliferation are poorly understood, and whether a soluble factor plays a major... 
SYNTHASE | RESPONSES | ENGRAFTMENT | ACTIVATION | PATHWAY | IMMUNOSUPPRESSION | GROWTH | HEMATOLOGY | MARROW STROMAL CELLS | INHIBIT | TRANSPLANTATION | CD8-Positive T-Lymphocytes - cytology | Dinoprostone - physiology | Humans | B-Lymphocyte Subsets - cytology | T-Lymphocyte Subsets - drug effects | CD8-Positive T-Lymphocytes - metabolism | Phosphorylation - drug effects | Macrophages - physiology | B-Lymphocyte Subsets - drug effects | Nitric Oxide - biosynthesis | Signal Transduction | CD4-Positive T-Lymphocytes - metabolism | Cell Division - drug effects | Receptors, Antigen, T-Cell - physiology | Mice, Knockout | B-Lymphocyte Subsets - metabolism | Mice | Tryptophan - pharmacology | HeLa Cells | Interleukin-2 - biosynthesis | Indoleamine-Pyrrole 2,3,-Dioxygenase - physiology | Nitric Oxide Synthase Type II - metabolism | Tetradecanoylphorbol Acetate - pharmacology | T-Lymphocyte Subsets - cytology | Concanavalin A - pharmacology | Nitric Oxide - pharmacology | STAT5 Transcription Factor - metabolism | Protein Processing, Post-Translational - drug effects | Nitric Oxide Synthase Type II - antagonists & inhibitors | Tryptophan - analogs & derivatives | Enzyme Induction - drug effects | Transforming Growth Factor beta - antagonists & inhibitors | Mesenchymal Stromal Cells - physiology | NG-Nitroarginine Methyl Ester - pharmacology | Transforming Growth Factor beta - immunology | Cell Line | Antigens, CD19 - analysis | CD4-Positive T-Lymphocytes - cytology | Mice, Inbred C57BL | Nitric Oxide Synthase Type II - deficiency | Nitric Oxide - physiology | Cyclooxygenase Inhibitors - pharmacology | Animals | Lymphocyte Activation - drug effects | CD8-Positive T-Lymphocytes - drug effects | Ionomycin - pharmacology | CD4-Positive T-Lymphocytes - drug effects | Indoleamine-Pyrrole 2,3,-Dioxygenase - antagonists & inhibitors | Interferon-gamma - biosynthesis | Prostaglandin-Endoperoxide Synthases - physiology | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, pp. e60144 - e60144
Lung transplantation is a recognised treatment for patients with end stage pulmonary disease. Transplant recipients receive life-long administration of... 
SOLID-ORGAN TRANSPLANTATION | NATURAL-KILLER-CELLS | LUNG TRANSPLANTATION | IN-VITRO | ACTIVATION | INHIBITION | MULTIDISCIPLINARY SCIENCES | PERIPHERAL-BLOOD | CYTOTOXICITY | MYCOPHENOLATE-MOFETIL | CYCLOSPORINE | Cyclosporine - pharmacology | Humans | Cells, Cultured | Morpholines - pharmacology | Male | Interferon-gamma - metabolism | Prednisolone - pharmacology | Lung Transplantation | Mycophenolic Acid - pharmacology | Acetophenones - pharmacology | Adult | Female | Lysosomal-Associated Membrane Protein 1 - metabolism | Flavonoids - pharmacology | Killer Cells, Natural - drug effects | Killer Cells, Natural - metabolism | Benzopyrans - pharmacology | Chromones - pharmacology | Immunosuppressive Agents - pharmacology | Killer cells | Corticosteroids | Analysis | Lung diseases | Immunotherapy | Transplantation of organs, tissues, etc | Organ transplant recipients | Mycophenolate mofetil | Drug therapy | T cells | Prednisolone | Mycophenolic acid | Lung | Cytotoxicity | Drug screening | Cell activation | Natural killer cells | Active control | Antigens | Cytokines | Medical treatment | Interleukin 12 | Rapamycin | T cell receptors | Patients | Immunosuppression | Major histocompatibility complex | Surveillance | γ-Interferon | Ligands | Drugs | Ionomycin | Transplants & implants | Toxicity | Cyclosporins | Medical services | Lung transplantation | Stimulation | Lymphocytes T | Transplantation | Activation | Kinases | Clinical outcomes | Immunosuppressive agents | Immunology | Pathways | Interleukin 2 | Lymphocytes | Xenografts | Immune system | Cytomegalovirus | Immune response | Cell survival | Graft rejection | Immune systems | Medicine | Rejection | Biopsy | Cell lines | Histocompatibility antigen HLA | Viral infections | Index Medicus
Journal Article
Bone, ISSN 8756-3282, 2005, Volume 37, Issue 2, pp. 148 - 158
Intermittent parathyroid hormone (PTH) application is an established pharmacological principle to stimulate bone formation. Yet, the molecular mechanisms... 
PTH and PTH/RP | Gene expression | Osteoblasts | Histomorphometry-animal | INTERMITTENT TREATMENT | ANABOLIC ACTION | PARATHYROID-HORMONE 1-34 | OSTEOPROGENITOR CELLS | OSTEOCLAST DIFFERENTIATION FACTOR | histomorphometry-animal | OVARIECTOMIZED RATS | TRABECULAR BONE | CANCELLOUS BONE | BMP ANTAGONIST | ENDOCRINOLOGY & METABOLISM | osteoblasts | gene expression | GROWTH-FACTOR-I | Bone Morphogenetic Proteins - antagonists & inhibitors | Tetradecanoylphorbol Acetate - pharmacology | Rats, Wistar | Parathyroid Hormone - pharmacology | Peptide Fragments - pharmacology | RNA, Messenger - metabolism | Skull - physiology | Peptide Fragments - physiology | Bone Morphogenetic Proteins - metabolism | Female | Protein Synthesis Inhibitors - pharmacology | Bone Morphogenetic Proteins - genetics | Skull - drug effects | Parathyroid Hormone - physiology | Cell Line | Bone Density | Ovariectomy | Colforsin - pharmacology | Tissue Culture Techniques | Rats | Femur - drug effects | Parathyroid Hormone - antagonists & inhibitors | Glycoproteins | RNA Stability | Cycloheximide - pharmacology | Femur - physiology | Cyclic AMP - antagonists & inhibitors | Animals | Peptide Fragments - antagonists & inhibitors | Genetic Markers - genetics | Ionomycin - pharmacology | Mice | Osteogenesis | Messenger RNA | Parathyroid hormone | Analysis | Genetic research | Protein biosynthesis | Bones | Peptide hormones | Density | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0132017 - e0132017
Decidualization of human endometrial stroma and gland development is mediated through cyclic AMP (cAMP), but the role of intracellular calcium ion (Ca2+) on... 
MENSTRUAL-CYCLE | CA2+ ENTRY | HUMAN DECIDUAL CELLS | ADENYLYL CYCLASES | MULTIDISCIPLINARY SCIENCES | GLANDULAR CELLS | PROLACTIN | DIFFERENTIATION | STROMAL CELLS | BINDING PROTEIN | CAMP | Biomarkers - metabolism | Cell Line | Calcium - pharmacology | Embryo Implantation - drug effects | Colforsin - pharmacology | Dinoprostone - biosynthesis | Humans | Stromal Cells - metabolism | Ions | Ryanodine Receptor Calcium Release Channel - metabolism | Chelating Agents - pharmacology | Dantrolene - pharmacology | Calcium Channel Blockers - pharmacology | Decidua - metabolism | Cyclic AMP - pharmacology | Models, Biological | Cyclooxygenase 2 - metabolism | Stromal Cells - drug effects | Female | Calcium Channels, L-Type - metabolism | Decidua - drug effects | Endometrium - cytology | Alamethicin - pharmacology | Ionophores - pharmacology | Calcium channels | Pituitary hormones | Ionophores | Protein binding | Nifedipine | Ionomycin | Transcription | Calcium | Laboratories | Epithelial cells | Insulin-like growth factor-binding protein 1 | Variations | Prostaglandin E2 | Intracellular signalling | Insulin-like growth factors | Calcium ionophores | Kinases | Calcium influx | Prostaglandin endoperoxide synthase | Calcium signalling | Proteins | Signal transduction | Prolactin | Physiology | Endometrium | Medical research | Calcium (intracellular) | Menstruation | Calcium channels (voltage-gated) | Cyclic AMP | Implantation | Pharmacology | Decidua | Breeding of animals | Gene expression | Embryos | Pharmacy | Calcium channels (L-type) | Forskolin | Cyclooxygenase-2 | Intracellular | Index Medicus
Journal Article
Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 01/2012, Volume 302, Issue 1, pp. L133 - L139
Journal Article